JSR Corp. (TYO:4185) is stepping up its efforts to develop new business in the company’s Life Sciences Corp. As one…...
Please subscribe to read the full story.
Selexis
JSR Will Buy Swiss Selexis to Expand Biopharma Business
JSR Corp. (TYO:4185) has announced plans to acquire Selexis SA, a company with specialized cell line generation technology. The Swiss…...
Please subscribe to read the full story.
